ABBV May 2024 80.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

88.15

0.00

(0.00%)

As of 03:31PM EDT. Market open.

Loading interactive chart…

PR Newswire
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders
AbbVie (NYSE: ABBV) and Gilgamesh Pharmaceuticals today announced a collaboration and option-to-license agreement to develop next-generation therapies for psychiatric disorders. This collaboration will leverage AbbVie's expertise in psychiatry and Gilgamesh's innovative research platform to discover novel neuroplastogens.
GOBankingRates
29 Huge Companies That You’ve Never Heard of Before and Their Stock Prices
You may think you know all of the big, powerful, multinational companies, from Walmart to Apple to Amazon. But you might be surprised at how many companies with tens of billions in annual revenue...
Zacks
Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
Ironwood (IRWD) incurs loss in the first quarter of 2024. Revenues decline year over year and miss estimates. The company lowers revenue guidance for 2024. Stock falls.